You searched for: «sculptra»
Results 56 - 60 of 111
Page 12 of 23
  1. Media
  2. Newsroom

Galderma delivers record net sales of 3.737 billion USD in the first nine months of 2025 and 15.0% year-on-year growth at constant currency, raises full-year guidance

Ad hoc announcement pursuant to Art. 53 LR

 

  1. Media
  2. Newsroom

Galderma delivers record first half 2025 net sales of 2.448 billion USD and 12.2% year-on-year growth at constant currency, raises full-year top-line guidance

Ad hoc announcement pursuant to Art. 53 LR

 

Zug, Switzerland, July 24, 2025 – Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced its financial results for the first half of 2025.

  1. Media
  2. Newsroom

Galderma achieves record 2 B USD net sales for a six-month period in H1 2023, as it continues to demonstrate leading execution and innovation capabilities in dermatology

Zug, Switzerland, July 27, 2023

  1. Media
  2. Newsroom

Galderma announces record 2023 net sales of over 4 B USD and significant core EBITDA margin expansion

Zug, Switzerland, February 29, 2024

 

Delivered against full year guidance for another consecutive year with strong financial performance

  1. Media
  2. Newsroom

AAD 2025: Galderma’s Scientific Presentations

Galderma will present updates from across its broad dermatology portfolio at the 2025 American Academy of Dermatology (AAD) Annual Meeting, taking place from March 7-11, 2025 in Orlando, Florida. The company will sponsor 22 e-posters – including two oral presentations – with updates on a number of its innovative products, including Nemluvio, Sculptra, Restylane and Relfydess.

Results 56 - 60 of 111
Page 12 of 23